Adicet Bio, Inc. Increase (Decrease) in Other Operating Liabilities
Adicet Bio, Inc. (ACET) reported Increase (Decrease) in Other Operating Liabilities of $1.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2020-11-05
- Adicet Bio, Inc. increase (decrease) in other operating liabilities for the quarter ending 2020-09-30 was -$18.00K.
- Adicet Bio, Inc. increase (decrease) in other operating liabilities for the quarter ending 2020-06-30 was $10.00K.
- Adicet Bio, Inc. increase (decrease) in other operating liabilities for the quarter ending 2020-03-31 was $9.00K.
- Adicet Bio, Inc. increase (decrease) in other operating liabilities for the quarter ending 2019-12-31 was $9.00K.
- Adicet Bio, Inc. increase (decrease) in other operating liabilities for fiscal 2019 was -$4.00K, a 121.05% decline from fiscal 2018.
- Adicet Bio, Inc. increase (decrease) in other operating liabilities for fiscal 2018 was $19.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$8.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.00K 10-Q · filed 2020-11-05 | $10.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $19.00K 10-Q · filed 2020-07-30 | $28.00K derived: sum of 3 quarters · filed 2020-07-30 | $23.00K derived: sum of 4 quarters · filed 2020-07-30 |
| 2020-03-31 | $9.00K 10-Q · filed 2020-05-07 | $18.00K derived: sum of 2 quarters · filed 2020-05-07 | $13.00K derived: sum of 3 quarters · filed 2020-05-07 | $9.00K derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $4.00K derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-07-30 | -$4.00K 10-K · filed 2020-03-12 |
| 2019-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$9.00K derived: sum of 2 quarters · filed 2020-07-30 | -$13.00K 10-Q · filed 2019-11-05 | -$16.00K derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$8.00K 10-Q · filed 2020-07-30 | -$11.00K derived: sum of 3 quarters · filed 2020-07-30 | -$14.00K derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | -$4.00K 10-Q · filed 2020-05-07 | -$7.00K derived: sum of 2 quarters · filed 2020-05-07 | -$10.00K derived: sum of 3 quarters · filed 2020-05-07 | -$13.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$6.00K derived: sum of 2 quarters · filed 2020-03-12 | -$9.00K derived: sum of 3 quarters · filed 2020-03-12 | $19.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$6.00K derived: sum of 2 quarters · filed 2019-11-05 | $22.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $25.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $28.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |